drugset / Trial / NCT00326209
Long-Term Safety and Tolerability of Mesalamine Pellets in Participants With Ulcerative Colitis in Remission
NaSingle-groupOpen-labelTreatment
Summary
To evaluate the long-term safety and tolerability of encapsulated mesalamine Granules (eMG) (formerly referred to as Mesalamine Pellets \[MP\]) in participants with ulcerative colitis currently in remission.
Timeline
- Start
- 2005-12-22
- Primary completion
- 2008-05-05
- Completion
- 2008-05-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mesalamine | Small molecule | 1.5 g | Oral |